Abstract
In a multicenter study of patients with painful functional bowel disorders (FBD), we compared the demographic, health status, and diagnostic features of patients with FBD and developed a functional bowel disorder severity index (FBDSI) for research and clinical care. Two hundred seventy patients with FBD in the United States, England, and Canada were surveyed on symptoms and health status, and their physicians made a diagnosis and rated illness severity as mild, moderate, or severe. Comparisons of 22 demographic and clinical variables were made by study site in addition to physicians' severity ratings. To develop the FBDSI, multiple regression analysis used the demographic and clinical variables to predict the physician's rating of severity. We found that most health status measures of patients with FBD across study sites are comparable and the derived and validated FBDSI scoring system uses three easy to obtain variables: FBDSI = [current pain by visual analog scale (0–100)] + [diagnosis of chronic functional abdominal pain (0 if absent and 106 if present)] + [number of physicians visits over previous six months × 11]. The FBDSI can be used to select patients for research protocols and/or follow their clinical outcome or response to treatments over time.
Similar content being viewed by others
References
Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G: Functional bowel disorders and chronic functional abdominal pain. Gastroenterol Int 5:75–91, 1992
Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE: Identification of subgroups of functional bowel disorders. Gastroenterol Int 3:159–172, 1990
Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds): Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. Boston, Little, Brown and Company, 1994
Harvey RF, Salih SY, Read AE: Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1:632–634, 1983
Mitchell CM, Drossman DA: Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 92:1282–1284, 1987
Drossman DA, Li Z, Andruzzi E, Temple R, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG: US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569–1580, 1993
Drossman DA: The functional gastrointestinal disorders and their diagnosis: A coming of age.In The Functional Gastrointestinal Disorders: Diagnosis: Pathophysiology and Treatment. DA Drossman, JE Richter, NJ Talley, WG Thompson, E Corazziari, WE Whitehead (eds). Boston, Little, Brown and Company, 1994, p 1
Drossman DA, Thompson WG: The irritable bowel syndrome: Review and a graduated, multicomponent treatment approach. Ann Intern Med 116:1009–1016, 1992
Sandler RS, Drossman DA, Nathan HP, McKee DC: Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 87:314–318, 1984
Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, Burger AL: Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95:701–708, 1988
Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III: Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 101:927–934, 1991
Heaton KW, O'Donnell LJD, Braddon FEM, Mountford RA, Hughes AO, Cripps PJ: Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 102:1962–1967, 1992
Talley NJ: Optimal design of treatment trials.In Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. DA Drossman, JE Richter, NJ Talley, WG Thompson, E Corazziari, WE Whitehead (eds). Boston, Little, Brown and Company, 1994, p 265
Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF: The irritable bowel syndrome: Toward optimal design of controlled treatment trials. Gastroenterol Int 4:189–211, 1993
Melzack R: The McGill pain questionnaire: Major properties and scoring methods. Pain 1:277–299, 1975
Koch GG, Edwards S: Clinical efficacy trials with categorical data.In Biopharmaceutical Statistics for Drug Development. KE Peace (ed). New York, Marcel Dekker, 1988
Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JWD: Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 106:287–296, 1994
Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF: The irritable bowel syndrome: Toward optimal design of controlled treatment trials. Gastroenterol Int 4:189–211, 1993
Best WR, Becktel JM, Singleton JW, Kern FJ: Development of a Crohn's disease activity index. National Cooperative Crohn's disease study. Gastroenterology 70:439–444, 1976
Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterol 107:271–293, 1994
Corney RH, Stanton R: Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 34:483–491, 1990
Drossman DA: Psychosocial factors in chronic functional abdominal pain.In Basic and Clinical Aspects of Chronic Abdominal Pain, Vol 9. EA Mayer, H Raybould (eds). Amsterdam, Elsevier Science Publishers, 1993, p 271
Guthrie E, Creed F, Dawson D, Tomenson B: A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 100:450–457, 1991
Whorwell PJ, Prior A, Colgan SM: Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut 28:423–425, 1987
Whitehead WE, Bosmajian L, Zonderman AB, Costa PTJ, Schuster MM: Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 95:709–714, 1988
Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM: Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 113:828–833, 1990
Thompson WG: C. Functional Bowel Disorders and D. Functional Abdominal Pain.In Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. DA Drossman, JE Richter, NJ Talley, WG Thompson, E Corazziari (eds). Boston, Little, Brown and Company, 1994, p 115
Duncan GH, Bushnell MC, Lavigne GJ: Comparison of verbal and visual analogue scales for measuring the intensity and unpleasantness of experimental pain. Pain 37:295–303, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drossman, D.A., Li, Z., Toner, B.B. et al. Functional bowel disorders. Digest Dis Sci 40, 986–995 (1995). https://doi.org/10.1007/BF02064187
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02064187